{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:20:34Z","timestamp":1769750434932,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.clon.2003.11.006","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T16:48:52Z","timestamp":1072111732000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Toxicity and Early Biochemical Outcomes From 125Iodine Prostate Brachytherapy in the U.K."],"prefix":"10.1016","volume":"16","author":[{"given":"A","family":"Henderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.A","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Loverock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.E.M","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W","family":"Laing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2003.11.006_BIB1","unstructured":"BAUS. Analyses of minimum data set for urological cancer. London: BAUS, 2001:39."},{"key":"10.1016\/j.clon.2003.11.006_BIB2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1464-410X.2002.02906.x","article-title":"Radical prostatectomy in Britain and Ireland at the millennium","volume":"90","author":"Ravichandran","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2003.11.006_BIB3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1464-410x.1999.00893.x","article-title":"Short-term morbidity and acceptability of 125iodine implantation for localized carcinoma of the prostate","volume":"83","author":"Al-Booz","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2003.11.006_BIB4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1464-410X.2002.02983.x","article-title":"125Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics","volume":"90","author":"Henderson","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2003.11.006_BIB5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000019549","article-title":"Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire","volume":"33","author":"Bates","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2003.11.006_BIB6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(99)00397-0","article-title":"Patient-reported urinary continence and sexual function after anatomic radical prostatectomy","volume":"55","author":"Walsh","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.clon.2003.11.006_BIB7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#","article-title":"Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up","volume":"89","author":"Ragde","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2003.11.006_BIB8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0360-3016(99)00499-X","article-title":"Palladium-103 brachytherapy for prostate carcinoma","volume":"46","author":"Blasko","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","article-title":"10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy","volume":"51","author":"Grimm","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1464-4096.2001.01610.x","article-title":"Prostate brachytherapy has come of age: a review of the technique and results","volume":"89","author":"Langley","year":"2002","journal-title":"Br J Urol"},{"issue":"252","key":"10.1016\/j.clon.2003.11.006_BIB11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0360-3016(02)03071-7","article-title":"Monotherapy for stage T1\/T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent prostate brachytherapy","volume":"54","author":"Potters","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"252","key":"10.1016\/j.clon.2003.11.006_BIB12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0360-3016(02)03122-X","article-title":"Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy >72 Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer","volume":"54","author":"Kupelian","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2003.11.006_BIB14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.1999.00121.x","article-title":"Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function","volume":"84","author":"Abrams","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2003.11.006_BIB15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1464-410x.2001.02253.x","article-title":"The optimal form of urinary drainage after acute retention of urine","volume":"88","author":"Patel","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2003.11.006_BIB16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clon.2003.11.006_BIB17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0360-3016(01)02675-X","article-title":"Erectile function after permanent prostate brachytherapy","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(02)03054-7","article-title":"Urethral and periurethral dosimetry in prostate brachytherapy: is there a convenient surrogate?","volume":"54","author":"Bucci","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0360-3016(01)02658-X","article-title":"Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation","volume":"52","author":"Crook","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0360-3016(01)02812-7","article-title":"Predictive factors of urinary retention following prostate brachytherapy","volume":"53","author":"Bucci","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB21","doi-asserted-by":"crossref","unstructured":"Altman DG. Practical statistics for medical research, 1st edn. London: Chapman and Hall, 1991.","DOI":"10.1201\/9780429258589"},{"key":"10.1016\/j.clon.2003.11.006_BIB22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0094-0143(21)00666-2","article-title":"Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores","volume":"22","author":"Barry","year":"1995","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clon.2003.11.006_BIB23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","article-title":"Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate","volume":"160","author":"Terk","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2003.11.006_BIB24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB25","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/1097-0142(20010601)91:11<2046::AID-CNCR1231>3.0.CO;2-W","article-title":"Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy","volume":"91","author":"Fulmer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2003.11.006_BIB26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(01)01578-4","article-title":"Potency after permanent prostate brachytherapy for localized prostate cancer","volume":"50","author":"Potters","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0090-4295(96)00666-8","article-title":"The PSA nadir that indicates potential cure after radiotherapy for prostate cancer","volume":"49","author":"Critz","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.clon.2003.11.006_BIB28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0360-3016(02)02717-7","article-title":"Post-treatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer","volume":"53","author":"Hanlon","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0360-3016(01)01594-2","article-title":"Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer","volume":"51","author":"Merrick","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2003.11.006_BIB31","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/S0360-3016(03)01046-0","article-title":"The 1999 patterns of care survey of radiation therapy in localized prostate cancer-a comprehensive survey of prostate brachytherapy in the United States","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2003.11.006_BIB32","first-page":"163","article-title":"Effects of neoadjuvant hormonal therapy on prostate biopsy results after 125I and 103Pd seed implantation","volume":"4","author":"Stone","year":"2000","journal-title":"Mol Urol"},{"key":"10.1016\/j.clon.2003.11.006_BIB33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0360-3016(01)02598-6","article-title":"Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation","volume":"52","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655503004242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655503004242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:23:49Z","timestamp":1760541829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655503004242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0936655503004242"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2003.11.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity and Early Biochemical Outcomes From 125Iodine Prostate Brachytherapy in the U.K.","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2003.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}